Expression of steroid and xenobiotic receptor in uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 835-839

  Yue, Xiaoni ^a,b   Utsunomiya, Hiroki ^a   Akahira, Jun Ichi ^a   Suzuki, Fumihiko ^a   Ito, Kiyoshi ^a   Nagase, Satoru ^a   Sasano, Hironobu ^a   Yaegashi, Nobuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUDAN UNIVERSITY   (China)

Author keywords

Histological scoring; Immunohistochemistry; Steroid and xenobiotic receptor; Uterine sarcoma

Indexed keywords

ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; STEROID AND XENOBIOTIC RECEPTOR; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENDOMETRIUM SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVERALL SURVIVAL; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL RATE; UTERUS CARCINOMA; UTERUS SARCOMA;

EID: 84872690275     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1094     Document Type: Article

References (20)

1. Akahira J, Tokunaga H, Toyoshima M, et al: Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Oncology 71: 333-340, 2006.
2. Curtin JP, Blessing JA, Soper JT, et al: Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol 83: 268-270, 2001.
3. Thigpen T, Blessing JA, Beecham J, et al: Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a gynecologic oncology group study. J Clin Oncol 9: 1962-1966, 1991.
4. Takara K, Takagi K, Tsujimoto M, et al: Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA. Biochem Biophys Res Commun 306: 116-120, 2003.
5. Miki Y, Suzuki T, Tazawa C, et al: Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol 231: 75-85, 2005.
6. Gupta D, Venkatesh M, Wang H, et al: Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer. Clin Cancer Res 14: 5332-5340, 2008.
7. Wang H, Huang H, Li H, et al: Activated pregnenolone X-receptor is a target for ketoconazole and its analogs. Clin Cancer Res 13: 2488-2495, 2007.
8. Masuyama H, Hiramatsu Y, Kodama J, et al: Expression and potential roles of pregnane X receptor in endometrial cancer. J Clin Endocrinol Metab 88: 4446-4454, 2003.
9. Miki Y, Suzuki T, Kitada K, et al: Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A in human breast carcinoma. Cancer Res 66: 535-542, 2006.
10. Masuyama H, Nakatsukasa H, Takamoto N, et al: Down-regulation of pregnane X receptor contributes to cell grown inhibitor and apoptosis by anticancer agents in endometrial cancer cells. Mol Pharmacol 72: 1045-1053, 2007.
11. Staudinger JL, Goodwin B, Jones SA, et al: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98: 3369-3374, 2001.
12. Xie W, Barwick JL, Downes M, et al: Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406: 435-439, 2000.
13. Masuyama H, Suwaki N, Tateishi Y, et al: The pregnane X receptor regulates gene expression in a ligand-and promoter-selective fashion. Mol Endocrinol 19: 1170-1180, 2005.
14. Yue X, Akahira J, Utsunomiya H, et al: Steroid and xenobiotic receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer. Pathl Int 60: 400-406, 2010.
15. Sasano H, Frost AR, Saitoh R, et al: Aromatase and 17β-hydroxysteroid dehydrogense type 1 in human breast carcinoma. J Clin Endocrinol Metab 81: 4042-4046, 1996.
16. Masuyama H, Hiramatsu Y, Mizutani H, et al: The expression of pregnane X receptor and its target gene, cytochrome P450 3A1 in perinatal mouse. Mol Cell Endocrinol 172: 47-56, 2001.
17. Blumberg B, Sabbagh W Jr, Juguilion H, et al: SXR, a novel and xenobiotic-sensing nuclear receptor. Genes Dev 12: 3195-3205, 1998.
18. Suzuki T, Moriya T, Sugawara A, et al: Retinoid receptor in human breast carcinoma: possible modulators of in situ estrogen metabolism. Breast Cancer Res Treat 65: 31-40, 2001.
19. Toyoshima M, Akahira J, Matsunaga G, et al: Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. Gynecol Oncol 94: 774-778, 2004.
20. Dotzlaw H, Leygue E, Watson P, et al: The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res 5: 2103-2107, 1999.